THU, MAY 28, 2020 12:15 CET Episurf Medical (NASDAQ: EPIS B) has received a Notice of Allowance from the Korean Intellectual Property Office (KIPO), implying the company’s first patent approval in Korea. The patent, entitled “System and method for creating a decision support material indicating damage to an anatomical joint” covers Episurf Medical’s 3D-based damage …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone